HopeStage
Back to all studies
Enrolling By InvitationNCT07569133

Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease

Device studyAges 40–90South KoreaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 40 years to 90 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 4, 2026
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
50
Sponsor
Ho-Won Lee
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
Device
Locations
South Korea
Age range
From 40 Years to 90 Years
Official registry ID
NCT07569133
Official title
Show the full official title

Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease : A Single-Center, Randomized, Double-Blinded, Sham-Controlled, Parallel-Design, Investigator-Initiated Exploratory Clinical Trial

Recruitment & locations

By invitation

Daegu

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Ho-Won Lee.

Who can participate?

Listed age limits: 40 years to 90 years.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies